SlideShare une entreprise Scribd logo
1  sur  36
The Economics of Public Health Care Reform
   in Advanced and Emerging Economies




                                                Benedict Clements
                                          Fiscal Affairs Department, IMF


                                                           March 2013

This presentation represents the views of the author and should not be attributed to the IMF, its Executive Board, or its management.
                                                                                                                                        1
This presentation is based on the book, The Economics of
 Public Health Care Reform in Advanced and Emerging Economies,
which draws on contributions from leading scholars in health
  economics from both advanced and emerging economies
                                                                 2
Outline


  I.     Fiscal context of health care reform

  II.    Trends and outlook for public health spending

  III.   Health care reform in advanced economies

  IV.    Health care reform in emerging economies

  V.     Summary


                                                         3
I. The fiscal
context of health
  care reform




                    4
I. Debt ratios remain at historic levels in advanced economies---
providing little room to accommodate higher spending on health
                                                                       Public Debt, percent of GDP

  140

                                                                                                                                                                    Great
  120                                                                                                                                                              Recession
                                                                World War II

  100


   80
                                                                                                                  Advanced

   60


   40


   20
                                                                                        Emerging
    0
                                                                                                           1950
        1880
               1885
                      1890
                             1895
                                    1900
                                           1905
                                                  1910
                                                         1915
                                                                1920
                                                                        1925
                                                                               1930
                                                                                      1935
                                                                                             1940
                                                                                                    1945


                                                                                                                  1955
                                                                                                                         1960
                                                                                                                                1965
                                                                                                                                       1970
                                                                                                                                              1975
                                                                                                                                                     1980
                                                                                                                                                            1985
                                                                                                                                                                    1990
                                                                                                                                                                           1995
                                                                                                                                                                                  2000
                                                                                                                                                                                         2005
                                                                                                                                                                                                2010
                                                                                                                                                                                                       5
II. Trends and
outlook of public
health spending




                    6
II. Led by public sector, large spending increases in advanced
economies over past 40 years
            Health spending in 27 advanced economies (percent of GDP)
   14



   12
                       Periods of Acceleration
   10
                                                        Private
    8



    6
                                                        Public
    4



    2



    0
     1970    1975     1980     1985       1990   1995     2000    2005   2010

                                                                                7
II. Increases in public health spending were much smaller in
emerging economies
           Health spending in 23 emerging economies (percent of GDP)
   6



   5



   4
                                                     Private

   3



   2
                                                     Public


   1



   0
    1970    1975     1980    1985     1990    1995     2000    2005    2010

                                                                              8
II. Higher health expenditure, however, does not necessarily lead
to better health outcomes

                                84                           Advanced Economies
                                                          Japan
                                                    Iceland
                                82          Australia       Italy    Switzerland
                                                        Spain
                                         Luxembourg           Sweden Canada
     Life expectancy at birth




                                               Norway                        Netherlands
                                                                        France
                                                      Ireland Belgium
                                80         Korea                         Germany
                                               Finland United Kingdom                                United States
                                                                       Denmark
                                             Slovenia          Portugal
                                78
                                             Czech Republic

                                76
                                                         Slovakia

                                74
                                     7        8      9     10       11   12   13     14    15   16      17   18
                                                  Total health expenditure as a percent of GDP (2010)

                                                                                                                     9
II. Main drivers of public health spending


     Population aging—explains about one fourth of the
      increase in spending-to-GDP ratios

     Excess Cost Growth (ECG) —the difference between
      real health expenditure growth and real GDP growth—
      explains the rest

         Technology
         Health policies and institutions
         Other factors



                                                            10
II. Public spending pressures in advanced countries are
substantial
        Projected increases in public health spending (percent of GDP), 2011-2030
   6
                                                                  Aging
                                                                  Excess cost growth
   5                                                              Weighted average=3.0
                                                                  Unweighted average=2.2

   4



   3



   2



   1



   0




                                                                                           11
II. Excess cost growth accounts for most of the increases in
public health spending in advanced Europe and the US
   9
                                      United States
   8                                  IMF advanced EU estimate
                                      European Commission advanced EU estimate 2012
   7

   6

   5

   4

   3

   2

   1

   0

                                                                                                                              2014
       1980
              1982
                     1984
                            1986
                                   1988
                                          1990
                                                 1992
                                                        1994
                                                               1996
                                                                      1998
                                                                             2000
                                                                                    2002
                                                                                           2004
                                                                                                  2006
                                                                                                         2008
                                                                                                                2010
                                                                                                                       2012


                                                                                                                                     2016
                                                                                                                                            2018
                                                                                                                                                   2020
                                                                                                                                                          2022
                                                                                                                                                                 2024
                                                                                                                                                                        2026
                                                                                                                                                                               2028
                                                                                                                                                                                      2030
                                                                                                                                                                                             12
II. Projected increases lower for emerging economies
         Projected increases in public health spending (percent of GDP), 2011-2030
   2.5
                                                                  Aging
                                                                  Excess cost growth

   2.0                                                            Weighted average=1.0
                                                                  Unweighted average=1.1



   1.5




   1.0




   0.5




   0.0




                                                                                           13
III. Health care
     reform in
    advanced
   economies



                   14
III. Three Methodologies



     Case studies

     Event analysis

     Econometric analysis linking indicators of health care
      systems and excess cost growth (ECG)




                                                               15
III. Our results suggest five viable options to contain public health
spending growth



      Budget caps (Italy, Sweden)

      Greater sub-national government involvement
       (Canada and Sweden), gate-keeping and case-
       based payment (Germany and Italy) – grouped
       under public management and coordination




                                                                        16
III. Our results suggest five viable options to contain public health
spending growth …

      Competition and choice (Germany)

      Greater reliance on private financing, especially
       of complementary health care outside public
       package (Australia, Canada, and France)

      Restricting the supply of health inputs and
       outputs (Canada)



                                                                        17
III. …which have the potential to contain projected increases in
public spending …
     Average Reform Impacts on Public Health Spending (percent of GDP), 2030
    0.6
                  (Decrease Relative to Benchmark Projections)


               0.49
    0.5



    0.4                           0.37


    0.3
                                                   0.26


    0.2



    0.1                                                          0.08
                                                                                  0.05

    0.0
          Competition and     Contracting and   Budget caps   Demand side   Supply constraints
             choice         public management




                                                                                                 18
III. … but subject to some caveats

     Simulated reform impacts need to be interpreted with
      caution

     Savings may not be large enough to avoid sizeable
      increases in spending some countries

     Therefore, deeper health reforms or cuts in other
      spending may be required to support required fiscal
      adjustment

     Reforms should ensure that health outcomes and
      access to care by the poor are not adversely affected


                                                              19
III. Some reforms don’t work in containing spending growth




     Price controls

     Deregulation of insurers

     Greater availability of information on the quality
      and price of health services to patients




                                                             20
III. Reform options depend on country characteristics and
projected growth
  For countries that rely more heavily on competition and
  choice:
  Low Excess Cost        Staying the course with marginal
  Growth (0-0.6):        reforms
  Canada, Czech
  Republic, France,
  Germany, Japan,
  and Slovakia

  Moderate Excess        Tightening budget constraints
  Cost Growth (0.6-      Strengthening gate-keeping
  1.0): Australia,       Increasing cost-sharing
  Austria, Belgium,
  and Netherlands
                                                            21
III. Reform options depend on country characteristics and
projected growth




  High Excess Cost      Tightening budget constraints
  Growth (greater       Increasing central oversight
  than 1.0): Greece,    Strengthening regulations of the
  Korea,                   workforce and equipment
  Luxembourg,           Strengthening gate-keeping
  Switzerland, and
  United States




                                                            22
III. Reform options depend on country characteristics and
projected growth

  For countries that rely more heavily on public insurance
  and provision:
  Low Excess Cost       Enhancing efficiency
  Growth (0-0.6):       Tightening budget caps
  Denmark, Ireland, Improving priority setting
  Italy, and Sweden
  Moderate Excess       Tightening macro-controls (including
  Cost Growth (0.6-        increasing central oversight)
  1.0): Norway and      Broadening insurance for over-the-
  Spain                    basic health care (increasing the
                           share of health expenditures
                           financed out of private
                           insurance)
                        Improving priority setting
                                                               23
III. Reform options depend on country characteristics and
projected growth




   High Excess Cost Strengthening supply constraints on
   Growth (Greater        workforce and equipment
   than 1.0): Iceland, Extending the role of private health
   Finland, Portugal,     insurance for over-the-basic
   New Zealand,           health care
   and the United      Increasing choice among providers
   Kingdom




                                                              24
III. Potential reforms not included in the analysis




      Improved health information technology (HIT)
       could help improve efficiency

      Greater emphasis on primary and preventive
       care could also contribute to expenditure
       containment




                                                      25
IV. Health care
    reform in
   emerging
  economies



                  26
IV. Emerging economies lag behind in health outcomes and
coverage


                                                       (% of GDP)
                                                                              Out-Of-Pocket
 85               Life Expectancy          35   10                            Private Insurance
                  Infant Mortality              9
                                           30                                 Public Insurance
 80                                             8

                                           25   7
                                                6
 75
                                           20   5
                                                4
                                           15
 70                                             3
                                           10   2
 65                                             1
                                           5    0
                                                     Advanced   Emerging   Emerging    Other
 60                                        0                     Europe     Latin     emerging
      Advanced Emerging Emerging Other                                     America
                Europe   Latin  emerging
                        America




                                                                                                  27
IV. Reform challenges differ between emerging Europe and
emerging Latin America and Asia



     In emerging Europe, coverage is almost complete;
      disease patterns mirror those in advanced economies;
      fiscal space is limited; must focus on efficiency-
      enhancing reforms

     In emerging Latin America and emerging Asia, disease
      patterns are transitioning from CDs to NCDs; these
      countries have greater fiscal space and need to expand
      coverage in a fiscally sustainable manner



                                                               28
IV. Emerging economies should learn from the experiences of
advanced economies



     Cost containment is one of the biggest challenges
      following a successful coverage expansion (Korea,
      Taiwan Province of China)

     The private sector can play an important role

     Improving efficiency is the key to long-term system
      performance




                                                              29
IV. A single payer system has several advantages

  This is suggested by reform experiences in both advanced and
  emerging economies (Estonia, Korea, Taiwan Province of China)


     It allows for more extensive risk pooling, and can help
      improve efficiency and control cost

     It provides a better platform to achieve equity

     It can also perform well in terms of promoting choice
      when combined with private provision



                                                                  30
IV. Health reform in emerging Europe



     Many countries have successfully contained spending
      through reforms (Estonia, Hungary, Latvia, Russia and
      Ukraine)

     There is scope for additional micro-level reforms to
      improve efficiency

     Promoting healthy behaviors is also important




                                                              31
IV. Health reform in emerging Latin America and Asia



     Benefit packages should be restricted to most essential
      services as coverage expands (China, India and
      Mexico)

     Expansion should be tax-financed if labor market
      informality is high

     Improvements in the composition of spending can lead
      to better health outcomes without incurring additional
      costs


                                                                32
V. Summary




             33
V. Summary
  For advanced economies:

        Fiscal adjustment needs are large and the projected
         increases in health spending account for a large
         share

        Health reforms can help contain projected spending
         increases

        The most effective strategy involves a mix of macro-
         level controls and micro-level reforms to improve
         spending efficiency

                                                                34
V. Summary
  For emerging economies:

        Fiscal adjustments needs are less pressing, but
         some economies are vulnerable

        Efficiency-enhancing reforms should be a priority,
         especially for emerging Europe

        Coverage expansion in emerging Latin America and
         Asia should not jeopardize fiscal sustainability




                                                              35
Available at IMF Bookstore and Amazon.com
    There is also an accompanying video

             Thank you!


                                            36

Contenu connexe

En vedette

Activity Rate Gender Nicola Salerno Cerm
Activity Rate Gender Nicola Salerno CermActivity Rate Gender Nicola Salerno Cerm
Activity Rate Gender Nicola Salerno CermNicola_C_Salerno
 
Nicola Salerno Trieste Ott 20 2012
Nicola Salerno Trieste Ott 20 2012Nicola Salerno Trieste Ott 20 2012
Nicola Salerno Trieste Ott 20 2012Nicola_C_Salerno
 
Health 2 0 Europe Presentation
Health 2 0 Europe PresentationHealth 2 0 Europe Presentation
Health 2 0 Europe PresentationHealth 2.0
 
Storia della Inflazione dalla Unificazione Nazionale a Oggi - Nsal
Storia della Inflazione dalla Unificazione Nazionale a Oggi - NsalStoria della Inflazione dalla Unificazione Nazionale a Oggi - Nsal
Storia della Inflazione dalla Unificazione Nazionale a Oggi - NsalNicola_C_Salerno
 
Gamification e Healthcare
Gamification e HealthcareGamification e Healthcare
Gamification e HealthcareOscar Lambrughi
 
La Governance della Spesa Farmaceutica H
La Governance della Spesa Farmaceutica HLa Governance della Spesa Farmaceutica H
La Governance della Spesa Farmaceutica HNicola_C_Salerno
 
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIA
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIAPresentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIA
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIANicola_C_Salerno
 
Riforma della Distribuzione del Farmaco
Riforma della Distribuzione del FarmacoRiforma della Distribuzione del Farmaco
Riforma della Distribuzione del FarmacoNicola_C_Salerno
 
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012SEminario di Nicola Salerno a UniFi il 25 Maggio 2012
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012Nicola_C_Salerno
 
Welfare Day Nc Salerno 2012
Welfare Day Nc Salerno 2012Welfare Day Nc Salerno 2012
Welfare Day Nc Salerno 2012Nicola_C_Salerno
 

En vedette (20)

sisvsp2012 sessione1_lucarelli_baussola_mussida
sisvsp2012 sessione1_lucarelli_baussola_mussidasisvsp2012 sessione1_lucarelli_baussola_mussida
sisvsp2012 sessione1_lucarelli_baussola_mussida
 
sisvsp2012 sessione5_cardacino_vignola
sisvsp2012 sessione5_cardacino_vignolasisvsp2012 sessione5_cardacino_vignola
sisvsp2012 sessione5_cardacino_vignola
 
sisvsp2012_sessione6_vignani_auci
sisvsp2012_sessione6_vignani_aucisisvsp2012_sessione6_vignani_auci
sisvsp2012_sessione6_vignani_auci
 
Activity Rate Gender Nicola Salerno Cerm
Activity Rate Gender Nicola Salerno CermActivity Rate Gender Nicola Salerno Cerm
Activity Rate Gender Nicola Salerno Cerm
 
Nicola Salerno Trieste Ott 20 2012
Nicola Salerno Trieste Ott 20 2012Nicola Salerno Trieste Ott 20 2012
Nicola Salerno Trieste Ott 20 2012
 
sisvsp2012_sessione3_mazziotta_bernardini_de gaetano_soriani
sisvsp2012_sessione3_mazziotta_bernardini_de gaetano_sorianisisvsp2012_sessione3_mazziotta_bernardini_de gaetano_soriani
sisvsp2012_sessione3_mazziotta_bernardini_de gaetano_soriani
 
Health 2 0 Europe Presentation
Health 2 0 Europe PresentationHealth 2 0 Europe Presentation
Health 2 0 Europe Presentation
 
Storia della Inflazione dalla Unificazione Nazionale a Oggi - Nsal
Storia della Inflazione dalla Unificazione Nazionale a Oggi - NsalStoria della Inflazione dalla Unificazione Nazionale a Oggi - Nsal
Storia della Inflazione dalla Unificazione Nazionale a Oggi - Nsal
 
Gamification e Healthcare
Gamification e HealthcareGamification e Healthcare
Gamification e Healthcare
 
La Governance della Spesa Farmaceutica H
La Governance della Spesa Farmaceutica HLa Governance della Spesa Farmaceutica H
La Governance della Spesa Farmaceutica H
 
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIA
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIAPresentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIA
Presentazione di Nicola C. Salerno a UNIFI: PROIEZIONI DI SPESA SANITARIA
 
sisvsp2012_sessione1_biffignandi_toninelli
sisvsp2012_sessione1_biffignandi_toninellisisvsp2012_sessione1_biffignandi_toninelli
sisvsp2012_sessione1_biffignandi_toninelli
 
Riforma della Distribuzione del Farmaco
Riforma della Distribuzione del FarmacoRiforma della Distribuzione del Farmaco
Riforma della Distribuzione del Farmaco
 
Lucca marzo 2013
Lucca marzo 2013Lucca marzo 2013
Lucca marzo 2013
 
The jobs crisis : trends and policy
The jobs crisis : trends and policyThe jobs crisis : trends and policy
The jobs crisis : trends and policy
 
sisvsp2012_sessione7_montella_righi
sisvsp2012_sessione7_montella_righisisvsp2012_sessione7_montella_righi
sisvsp2012_sessione7_montella_righi
 
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012SEminario di Nicola Salerno a UniFi il 25 Maggio 2012
SEminario di Nicola Salerno a UniFi il 25 Maggio 2012
 
sisvsp2012_sessione4_fusco_de francesco_moretti_mortara_broccoli
sisvsp2012_sessione4_fusco_de francesco_moretti_mortara_broccolisisvsp2012_sessione4_fusco_de francesco_moretti_mortara_broccoli
sisvsp2012_sessione4_fusco_de francesco_moretti_mortara_broccoli
 
Welfare Day Nc Salerno 2012
Welfare Day Nc Salerno 2012Welfare Day Nc Salerno 2012
Welfare Day Nc Salerno 2012
 
sisvsp2012_sessione7_albisinni_marzilli_pintaldi
sisvsp2012_sessione7_albisinni_marzilli_pintaldisisvsp2012_sessione7_albisinni_marzilli_pintaldi
sisvsp2012_sessione7_albisinni_marzilli_pintaldi
 

Similaire à Ben Clements, Fiscal Affairs Department, IMF

Rayjay Ambekar on valuations, asset allocation and markets
Rayjay Ambekar on valuations, asset allocation and marketsRayjay Ambekar on valuations, asset allocation and markets
Rayjay Ambekar on valuations, asset allocation and marketsmoneyweb
 
How rising values influence our markets
How rising values influence our marketsHow rising values influence our markets
How rising values influence our marketsMark Taylor
 
Introduction of short duration pulses into rice-based cropping systems in wes...
Introduction of short duration pulses into rice-based cropping systems in wes...Introduction of short duration pulses into rice-based cropping systems in wes...
Introduction of short duration pulses into rice-based cropping systems in wes...ACIAR
 
P 3.1 Innovations for Better Livelihoods
P 3.1 Innovations for Better LivelihoodsP 3.1 Innovations for Better Livelihoods
P 3.1 Innovations for Better LivelihoodsGCARD Conferences
 
Crop Presentation (10.12.07)
Crop Presentation (10.12.07)Crop Presentation (10.12.07)
Crop Presentation (10.12.07)apulvermache
 
What is Just: Education, Excellence and Equity
What is Just: Education, Excellence and Equity What is Just: Education, Excellence and Equity
What is Just: Education, Excellence and Equity Laurie Posner
 
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...ILRI
 
Energy Efficiency: Challenges and Opportunities
Energy Efficiency: Challenges and OpportunitiesEnergy Efficiency: Challenges and Opportunities
Energy Efficiency: Challenges and OpportunitiesAlliance To Save Energy
 
Municipal Credit Scoring
Municipal Credit ScoringMunicipal Credit Scoring
Municipal Credit ScoringMarc Joffe
 
国土の長期展望に向けた検討の方向性について2010/12/17
国土の長期展望に向けた検討の方向性について2010/12/17国土の長期展望に向けた検討の方向性について2010/12/17
国土の長期展望に向けた検討の方向性について2010/12/17Nagayama Shinichi
 
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08Charles Darwin University
 
globalisation-ppt
 globalisation-ppt globalisation-ppt
globalisation-pptpavitarsidhu
 
Europe’s competitiveness presentation for garagerasmus
Europe’s competitiveness presentation for garagerasmusEurope’s competitiveness presentation for garagerasmus
Europe’s competitiveness presentation for garagerasmusgaragErasmus Foundation
 
201110128 frankfurt beetle_final
201110128 frankfurt beetle_final201110128 frankfurt beetle_final
201110128 frankfurt beetle_finalbrianlimp13
 
Erwin Rode on Prospects for Property
Erwin Rode on Prospects for PropertyErwin Rode on Prospects for Property
Erwin Rode on Prospects for Propertymoneyweb
 

Similaire à Ben Clements, Fiscal Affairs Department, IMF (20)

E ciencia
E cienciaE ciencia
E ciencia
 
Rayjay Ambekar on valuations, asset allocation and markets
Rayjay Ambekar on valuations, asset allocation and marketsRayjay Ambekar on valuations, asset allocation and markets
Rayjay Ambekar on valuations, asset allocation and markets
 
How rising values influence our markets
How rising values influence our marketsHow rising values influence our markets
How rising values influence our markets
 
For Richer or Poorer
For Richer or PoorerFor Richer or Poorer
For Richer or Poorer
 
Introduction of short duration pulses into rice-based cropping systems in wes...
Introduction of short duration pulses into rice-based cropping systems in wes...Introduction of short duration pulses into rice-based cropping systems in wes...
Introduction of short duration pulses into rice-based cropping systems in wes...
 
P 3.1 Innovations for Better Livelihoods
P 3.1 Innovations for Better LivelihoodsP 3.1 Innovations for Better Livelihoods
P 3.1 Innovations for Better Livelihoods
 
Asset class iq_0812
Asset class iq_0812Asset class iq_0812
Asset class iq_0812
 
Crop Presentation (10.12.07)
Crop Presentation (10.12.07)Crop Presentation (10.12.07)
Crop Presentation (10.12.07)
 
What is Just: Education, Excellence and Equity
What is Just: Education, Excellence and Equity What is Just: Education, Excellence and Equity
What is Just: Education, Excellence and Equity
 
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...
Four degrees and beyond: What might this mean for agriculture in sub-Saharan ...
 
CPWF Overview
CPWF OverviewCPWF Overview
CPWF Overview
 
Energy Efficiency: Challenges and Opportunities
Energy Efficiency: Challenges and OpportunitiesEnergy Efficiency: Challenges and Opportunities
Energy Efficiency: Challenges and Opportunities
 
Deportations under Obama
Deportations under ObamaDeportations under Obama
Deportations under Obama
 
Municipal Credit Scoring
Municipal Credit ScoringMunicipal Credit Scoring
Municipal Credit Scoring
 
国土の長期展望に向けた検討の方向性について2010/12/17
国土の長期展望に向けた検討の方向性について2010/12/17国土の長期展望に向けた検討の方向性について2010/12/17
国土の長期展望に向けた検討の方向性について2010/12/17
 
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08
Knowing & Learning To Deal With Climate Change Act Km Canberra 14.10.08
 
globalisation-ppt
 globalisation-ppt globalisation-ppt
globalisation-ppt
 
Europe’s competitiveness presentation for garagerasmus
Europe’s competitiveness presentation for garagerasmusEurope’s competitiveness presentation for garagerasmus
Europe’s competitiveness presentation for garagerasmus
 
201110128 frankfurt beetle_final
201110128 frankfurt beetle_final201110128 frankfurt beetle_final
201110128 frankfurt beetle_final
 
Erwin Rode on Prospects for Property
Erwin Rode on Prospects for PropertyErwin Rode on Prospects for Property
Erwin Rode on Prospects for Property
 

Plus de Investnet

Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerGrainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerInvestnet
 
Dr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianDr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianInvestnet
 
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalGerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalInvestnet
 
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Investnet
 
Healthbridge
HealthbridgeHealthbridge
HealthbridgeInvestnet
 
Think Biosolution
Think BiosolutionThink Biosolution
Think BiosolutionInvestnet
 
Malcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorMalcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorInvestnet
 
Control Drink
Control DrinkControl Drink
Control DrinkInvestnet
 
Robert Kelly, Videodoc
Robert Kelly, VideodocRobert Kelly, Videodoc
Robert Kelly, VideodocInvestnet
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Investnet
 
Anastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalAnastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalInvestnet
 
Sasha Oliver, Avloni
Sasha Oliver, AvloniSasha Oliver, Avloni
Sasha Oliver, AvloniInvestnet
 
Jemma Gatliff, Keregen
Jemma Gatliff, KeregenJemma Gatliff, Keregen
Jemma Gatliff, KeregenInvestnet
 
Darren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesDarren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesInvestnet
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision TheraputicsInvestnet
 
Niamh Malone , Brainey App
Niamh Malone , Brainey App Niamh Malone , Brainey App
Niamh Malone , Brainey App Investnet
 
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsToby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsInvestnet
 
Ena Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersEna Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersInvestnet
 
Cathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalCathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalInvestnet
 
Kieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseKieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseInvestnet
 

Plus de Investnet (20)

Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerGrainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
 
Dr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianDr Neil Black , Consultant Physician
Dr Neil Black , Consultant Physician
 
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalGerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
 
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
 
Healthbridge
HealthbridgeHealthbridge
Healthbridge
 
Think Biosolution
Think BiosolutionThink Biosolution
Think Biosolution
 
Malcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorMalcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer Survivor
 
Control Drink
Control DrinkControl Drink
Control Drink
 
Robert Kelly, Videodoc
Robert Kelly, VideodocRobert Kelly, Videodoc
Robert Kelly, Videodoc
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
 
Anastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalAnastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously Digital
 
Sasha Oliver, Avloni
Sasha Oliver, AvloniSasha Oliver, Avloni
Sasha Oliver, Avloni
 
Jemma Gatliff, Keregen
Jemma Gatliff, KeregenJemma Gatliff, Keregen
Jemma Gatliff, Keregen
 
Darren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesDarren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio Sciences
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision Theraputics
 
Niamh Malone , Brainey App
Niamh Malone , Brainey App Niamh Malone , Brainey App
Niamh Malone , Brainey App
 
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsToby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
 
Ena Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersEna Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare Partners
 
Cathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalCathal Friel, Raglan Capital
Cathal Friel, Raglan Capital
 
Kieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseKieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT Hothouse
 

Ben Clements, Fiscal Affairs Department, IMF

  • 1. The Economics of Public Health Care Reform in Advanced and Emerging Economies Benedict Clements Fiscal Affairs Department, IMF March 2013 This presentation represents the views of the author and should not be attributed to the IMF, its Executive Board, or its management. 1
  • 2. This presentation is based on the book, The Economics of Public Health Care Reform in Advanced and Emerging Economies, which draws on contributions from leading scholars in health economics from both advanced and emerging economies 2
  • 3. Outline I. Fiscal context of health care reform II. Trends and outlook for public health spending III. Health care reform in advanced economies IV. Health care reform in emerging economies V. Summary 3
  • 4. I. The fiscal context of health care reform 4
  • 5. I. Debt ratios remain at historic levels in advanced economies--- providing little room to accommodate higher spending on health Public Debt, percent of GDP 140 Great 120 Recession World War II 100 80 Advanced 60 40 20 Emerging 0 1950 1880 1885 1890 1895 1900 1905 1910 1915 1920 1925 1930 1935 1940 1945 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 5
  • 6. II. Trends and outlook of public health spending 6
  • 7. II. Led by public sector, large spending increases in advanced economies over past 40 years Health spending in 27 advanced economies (percent of GDP) 14 12 Periods of Acceleration 10 Private 8 6 Public 4 2 0 1970 1975 1980 1985 1990 1995 2000 2005 2010 7
  • 8. II. Increases in public health spending were much smaller in emerging economies Health spending in 23 emerging economies (percent of GDP) 6 5 4 Private 3 2 Public 1 0 1970 1975 1980 1985 1990 1995 2000 2005 2010 8
  • 9. II. Higher health expenditure, however, does not necessarily lead to better health outcomes 84 Advanced Economies Japan Iceland 82 Australia Italy Switzerland Spain Luxembourg Sweden Canada Life expectancy at birth Norway Netherlands France Ireland Belgium 80 Korea Germany Finland United Kingdom United States Denmark Slovenia Portugal 78 Czech Republic 76 Slovakia 74 7 8 9 10 11 12 13 14 15 16 17 18 Total health expenditure as a percent of GDP (2010) 9
  • 10. II. Main drivers of public health spending  Population aging—explains about one fourth of the increase in spending-to-GDP ratios  Excess Cost Growth (ECG) —the difference between real health expenditure growth and real GDP growth— explains the rest  Technology  Health policies and institutions  Other factors 10
  • 11. II. Public spending pressures in advanced countries are substantial Projected increases in public health spending (percent of GDP), 2011-2030 6 Aging Excess cost growth 5 Weighted average=3.0 Unweighted average=2.2 4 3 2 1 0 11
  • 12. II. Excess cost growth accounts for most of the increases in public health spending in advanced Europe and the US 9 United States 8 IMF advanced EU estimate European Commission advanced EU estimate 2012 7 6 5 4 3 2 1 0 2014 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2016 2018 2020 2022 2024 2026 2028 2030 12
  • 13. II. Projected increases lower for emerging economies Projected increases in public health spending (percent of GDP), 2011-2030 2.5 Aging Excess cost growth 2.0 Weighted average=1.0 Unweighted average=1.1 1.5 1.0 0.5 0.0 13
  • 14. III. Health care reform in advanced economies 14
  • 15. III. Three Methodologies  Case studies  Event analysis  Econometric analysis linking indicators of health care systems and excess cost growth (ECG) 15
  • 16. III. Our results suggest five viable options to contain public health spending growth  Budget caps (Italy, Sweden)  Greater sub-national government involvement (Canada and Sweden), gate-keeping and case- based payment (Germany and Italy) – grouped under public management and coordination 16
  • 17. III. Our results suggest five viable options to contain public health spending growth …  Competition and choice (Germany)  Greater reliance on private financing, especially of complementary health care outside public package (Australia, Canada, and France)  Restricting the supply of health inputs and outputs (Canada) 17
  • 18. III. …which have the potential to contain projected increases in public spending … Average Reform Impacts on Public Health Spending (percent of GDP), 2030 0.6 (Decrease Relative to Benchmark Projections) 0.49 0.5 0.4 0.37 0.3 0.26 0.2 0.1 0.08 0.05 0.0 Competition and Contracting and Budget caps Demand side Supply constraints choice public management 18
  • 19. III. … but subject to some caveats  Simulated reform impacts need to be interpreted with caution  Savings may not be large enough to avoid sizeable increases in spending some countries  Therefore, deeper health reforms or cuts in other spending may be required to support required fiscal adjustment  Reforms should ensure that health outcomes and access to care by the poor are not adversely affected 19
  • 20. III. Some reforms don’t work in containing spending growth  Price controls  Deregulation of insurers  Greater availability of information on the quality and price of health services to patients 20
  • 21. III. Reform options depend on country characteristics and projected growth For countries that rely more heavily on competition and choice: Low Excess Cost Staying the course with marginal Growth (0-0.6): reforms Canada, Czech Republic, France, Germany, Japan, and Slovakia Moderate Excess Tightening budget constraints Cost Growth (0.6- Strengthening gate-keeping 1.0): Australia, Increasing cost-sharing Austria, Belgium, and Netherlands 21
  • 22. III. Reform options depend on country characteristics and projected growth High Excess Cost Tightening budget constraints Growth (greater Increasing central oversight than 1.0): Greece, Strengthening regulations of the Korea, workforce and equipment Luxembourg, Strengthening gate-keeping Switzerland, and United States 22
  • 23. III. Reform options depend on country characteristics and projected growth For countries that rely more heavily on public insurance and provision: Low Excess Cost Enhancing efficiency Growth (0-0.6): Tightening budget caps Denmark, Ireland, Improving priority setting Italy, and Sweden Moderate Excess Tightening macro-controls (including Cost Growth (0.6- increasing central oversight) 1.0): Norway and Broadening insurance for over-the- Spain basic health care (increasing the share of health expenditures financed out of private insurance) Improving priority setting 23
  • 24. III. Reform options depend on country characteristics and projected growth High Excess Cost Strengthening supply constraints on Growth (Greater workforce and equipment than 1.0): Iceland, Extending the role of private health Finland, Portugal, insurance for over-the-basic New Zealand, health care and the United Increasing choice among providers Kingdom 24
  • 25. III. Potential reforms not included in the analysis  Improved health information technology (HIT) could help improve efficiency  Greater emphasis on primary and preventive care could also contribute to expenditure containment 25
  • 26. IV. Health care reform in emerging economies 26
  • 27. IV. Emerging economies lag behind in health outcomes and coverage (% of GDP) Out-Of-Pocket 85 Life Expectancy 35 10 Private Insurance Infant Mortality 9 30 Public Insurance 80 8 25 7 6 75 20 5 4 15 70 3 10 2 65 1 5 0 Advanced Emerging Emerging Other 60 0 Europe Latin emerging Advanced Emerging Emerging Other America Europe Latin emerging America 27
  • 28. IV. Reform challenges differ between emerging Europe and emerging Latin America and Asia  In emerging Europe, coverage is almost complete; disease patterns mirror those in advanced economies; fiscal space is limited; must focus on efficiency- enhancing reforms  In emerging Latin America and emerging Asia, disease patterns are transitioning from CDs to NCDs; these countries have greater fiscal space and need to expand coverage in a fiscally sustainable manner 28
  • 29. IV. Emerging economies should learn from the experiences of advanced economies  Cost containment is one of the biggest challenges following a successful coverage expansion (Korea, Taiwan Province of China)  The private sector can play an important role  Improving efficiency is the key to long-term system performance 29
  • 30. IV. A single payer system has several advantages This is suggested by reform experiences in both advanced and emerging economies (Estonia, Korea, Taiwan Province of China)  It allows for more extensive risk pooling, and can help improve efficiency and control cost  It provides a better platform to achieve equity  It can also perform well in terms of promoting choice when combined with private provision 30
  • 31. IV. Health reform in emerging Europe  Many countries have successfully contained spending through reforms (Estonia, Hungary, Latvia, Russia and Ukraine)  There is scope for additional micro-level reforms to improve efficiency  Promoting healthy behaviors is also important 31
  • 32. IV. Health reform in emerging Latin America and Asia  Benefit packages should be restricted to most essential services as coverage expands (China, India and Mexico)  Expansion should be tax-financed if labor market informality is high  Improvements in the composition of spending can lead to better health outcomes without incurring additional costs 32
  • 34. V. Summary For advanced economies:  Fiscal adjustment needs are large and the projected increases in health spending account for a large share  Health reforms can help contain projected spending increases  The most effective strategy involves a mix of macro- level controls and micro-level reforms to improve spending efficiency 34
  • 35. V. Summary For emerging economies:  Fiscal adjustments needs are less pressing, but some economies are vulnerable  Efficiency-enhancing reforms should be a priority, especially for emerging Europe  Coverage expansion in emerging Latin America and Asia should not jeopardize fiscal sustainability 35
  • 36. Available at IMF Bookstore and Amazon.com There is also an accompanying video Thank you! 36

Notes de l'éditeur

  1. Fiscal risks continue to be elevated, though less acute than six months ago.In advanced economies, debt to GDP ratios remain at historic levels, last seen during World War II, and are still rising. In emerging economies, the bump in debt to GDP during the crisis has reversed somewhat. However, they are still exposed to negative spillovers if global conditions deteriorate (will come back to this later in the presentation).
  2. In this light, most advanced economies and several emerging economies will need to undertake substantial adjustment over the coming decade to bring debt to GDP down to appropriate levels. The Fiscal Monitor has a standard exercise to calculate the illustrative adjustment needs required between now and 2020, and then sustained for a decade beyond that, to bring debt ratios to 60 percent for advanced economies, and 40 percent for emerging economies. This threshold represents the median debt to GDP ratio before the crisis. For this Fiscal Monitor, the methodology used for the calculation of the illustrative adjustment needs was modified to endogenize the interest rate growth differential, by allowing both interest rates and growth to be affected by each country’s debt level. For advanced economies, the required adjustment needs average 8 percent of GDP, considerably higher in the case of Japan and the US. Emerging economies are in better shape, even under the lower debt threshold. The required adjustment need is 1 percent of GDP on average. If in addition, age-related spending costs are taken into account, adjustment needs would jump to 12 percent of GDP in advanced economies and 4 percent in emerging economies. The challenge is not only to improve the primary balances, but to sustain them over a substantial number of years. For many countries, measures have already been approved and progress has been made. Some countries are still far off, most notably in Japan and the US. For the US a credible adjustment plan is needed, that includes entitlement reforms to reduce the cost of pensions and especially healthcare. Revenue measures will also be needed, including widening tax bases by reducing tax expenditures. For Japan, a more ambitious plan is needed that includes tax reform that gradually increases the consumption tax beyond current plans, as well as entitlement reforms. [Possible questions:Why these debt thresholds?This is an illustrative exercise. The thresholds of 60 percent of GDP for advanced economies and 40 percent of GDP for emerging economies represent the median debt to GDP ratio before the crisis.How does the new methodology compare to the previous one?The revised methodology takes into account the effects of high debt on interest rates and GDP growth. With this revised methodology, some countries would see higher adjustment needs (for example Italy and Japan), and others lower adjustment needs (for example Germany and France).]